US Congress House Resolution 343 (Prior Session Legislation)

---

Sponsorship: Partisan Bill (Democrat 1)
Status: Introduced on July 8 2011 - 25% progression, died in committee
Action: 2011-08-25 - Referred to the Subcommittee on the Constitution.
Pending: House Subcommittee on the Constitution Committee
Text: Latest bill text (Introduced) [PDF]

Disapproves of the majority opinion in Sorrell v. IMS Health Inc., because it puts prescribers at risk of having their prescriber-identifying information sold without their knowledge or consent. Expresses the belief of the House of Representatives that: (1) the Supreme Court incorrectly applied a heightened First Amendment standard of review to an instance of commercial regulation; (2) the negative impact on a pharmaceutical manufacturer's ability to market its products is outweighed by the interests of patient safety, doctor privacy, and health care costs; and (3) the states have the right to regulate the pharmaceutical industry based on what is best for the health and safety of their residents.

Expressing disapproval of the decision by the Supreme Court in Sorrell v. IMS Health Inc.

Sen. Edward Markey [D-MA]

Date	Chamber	Action
2011-08-25	House	Referred to the Subcommittee on the Constitution.
2011-07-15	House	Referred to the Subcommittee on Health.
2011-07-08	House	Referred to House Judiciary
2011-07-08	House	Referred to House Energy and Commerce
2011-07-08	House	Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Type	Source
Summary	https://www.congress.gov/bill/112th-congress/house-resolution/343/all-info
Text	https://www.congress.gov/112/bills/hres343/BILLS-112hres343ih.pdf